NXENNexien BioPharma, Inc.

About Nexien BioPharma, Inc. (NXEN)

Nexien BioPharma, Inc. (NXEN) is a Drug Manufacturers - Specialty & Generic company headquartered in Glendale, CO, United States whose shares trade over-the-counter on the Pink tier.

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s).

Products and services

The Company's business is to pursue pre-clinical and drug development activities, in accordance with U.S. Food and Drug Administration (“FDA”) protocols, for certain pharmaceutical formulations that include cannabinoids. It is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders and medical conditions.

NXEN key facts

Ticker symbol

NXEN

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Glendale, CO, United States

Country of incorporation

US

Year of incorporation

1952

Employees

3

Estimated market cap

$686.5K (as of May 13, 2025)

Shares outstanding

70,772,196

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

6/30

Nexien BioPharma, Inc. leadership

• Richard Greenberg — CEO
• Robert Goldfarb — COO
• Evan Wasoff — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with N